BALYASNY ASSET MANAGEMENT L.P. - BIOPLUS ACQUISITION CORP ownership

BIOPLUS ACQUISITION CORP's ticker is and the CUSIP is G11217117. A total of 66 filers reported holding BIOPLUS ACQUISITION CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of BIOPLUS ACQUISITION CORP
ValueSharesWeighting
Q1 2023$2,610,000
+1.6%
250,0000.0%0.01%0.0%
Q4 2022$2,570,000
+2.4%
250,0000.0%0.01%
-12.5%
Q3 2022$2,509,000
-0.2%
250,0000.0%0.01%0.0%
Q2 2022$2,513,000
+69.6%
250,000
+66.7%
0.01%
+60.0%
Q1 2022$1,482,000150,0000.01%
Other shareholders
BIOPLUS ACQUISITION CORP shareholders Q2 2022
NameSharesValueWeighting ↓
Radcliffe Capital Management, L.P. 718,701$7,790,6470.97%
BERKLEY W R CORP 1,119,638$12,125,6800.79%
First Trust Capital Management L.P. 1,106,378$11,993,0270.66%
COWEN AND COMPANY, LLC 679,393$7,364,5520.52%
Westchester Capital Management, LLC 1,390,000$15,053,7010.44%
METEORA CAPITAL, LLC 235,256$2,550,1520.44%
BCK CAPITAL MANAGEMENT LP 74,268$805,0580.41%
Exos TFP Holdings LLC 60,000$650,4000.35%
PERISCOPE CAPITAL INC. 250,000$2,709,9750.31%
FIR TREE CAPITAL MANAGEMENT LP 230,111$2,492,1020.26%
View complete list of BIOPLUS ACQUISITION CORP shareholders